(Act161) Act 161 Session Laws of Hawaii 2018 established the medical cannabis insurance reimbursement working group to address the complexities surrounding the topic of making medical cannabis reimbursable by health insurance. The working group will consider the following when making recommendations in its report to the legislature:

• Actions taken in other states;
• Potential parallel reimbursement models for other types of non-prescription therapies;
• Associated liability issues for health plans;
• Potential impact on insurance premiums;
• Insurance riders for alternative therapies, which could serve as a model for medical cannabis reimbursement; and
• Other relevant issues that may arise, at the discretion of the working group